ArticlemAbs
Generation and engineering of potent single domain antibody-based bispecific IL-18 mimetics resistant to IL-18BP decoy receptor inhibition.
Britta Lipinski et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
cites it